Literature DB >> 30048149

MIBG (metaiodobenzylguanidine) theranostics in pediatric and adult malignancies.

Archi Agrawal1, Venkatesh Rangarajan1, Sneha Shah1, Ameya Puranik1, Nilendu Purandare1.   

Abstract

Metaiodobenzylguanidine, a guanithidine analog, labeled with 123I and 131I, is used for imaging and therapy of neuroblastomas and various neural crest tumors like paragangliomas, pheochromocytomas, medullary cancer of thyroid and carcinoids since the past three to four decades. In this review article, we shall revisit metaiodobenzylguanidine as a radiopharmaceutical and its various applications in neural crest tumors.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30048149      PMCID： PMC6475939          DOI： 10.1259/bjr.20180103

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


  5 in total

1.  A Durable Response With the Combination of Nivolumab and Cabozantinib in a Patient With Metastatic Paraganglioma: A Case Report and Review of the Current Literature.

Authors:  Minas P Economides; Amishi Y Shah; Camilo Jimenez; Mouhammed A Habra; Monica Desai; Matthew T Campbell
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-27       Impact factor: 5.555

Review 2.  Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?

Authors:  Sergio Di Molfetta; Andrea Dotto; Giuseppe Fanciulli; Tullio Florio; Tiziana Feola; Annamaria Colao; Antongiulio Faggiano
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-14       Impact factor: 5.555

3.  Designing and Comparing Performances of Image Processing Pipeline for Enhancement of I-131-metaiodobenzylguanidine Images.

Authors:  Anil Kumar Pandey; Shweta Dhiman; Sreedharan Thankarajan ArunRaj; Chetan Patel; Chandrashekhar Bal; Rakesh Kumar
Journal:  Indian J Nucl Med       Date:  2021-06-21

Review 4.  Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors.

Authors:  Andrea Cimini; Maria Ricci; Agostino Chiaravalloti; Luca Filippi; Orazio Schillaci
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

5.  Paediatric Horner Syndrome: How much further to investigate?

Authors:  Manjushree Bhate; Maree Flaherty; Neil Rowe; Robert Howman-Giles
Journal:  Indian J Ophthalmol       Date:  2020-11       Impact factor: 1.848
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.